Identifying Patterns in the Breath of Individuals With Breast Cancer
Breathe BioMedical Inc · with Mayo Clinic, George Washington University · NCT06512350
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 40–74 · Women only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 5175
- US sites recruiting
- 3
- Study start
- February 25, 2025
- Record last updated
- September 18, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Researchers will compare the breath profiles of women with breast cancer and those without to determine whether there are disease-specific patterns that can be leveraged to facilitate breast cancer detection.
Women with mammogram-confirmed breast tissue density undergoing standard-of-care breast cancer screening will be invited to participate. Those who provide informed consent will provide one breath sample and fill out a questionnaire about their medical history with help from the research coordinators. Breath samples will be collected prior to standard of care biopsy or MRI, and patients will be stratified into the case or control group based on their test results.
The primary goal of this project is to use exhaled alveolar breath and the subsequent spectral data produced by Breathe BioMedical's cavity ring-down spectrometer to further develop Breathe BioMedical's technology and machine learning algorithms to determine the feasibility of detecting breast cancer in women aged 40 to 74.
Secondarily, this project aims to identify patterns of VOCs that are either over- or under-represented in participants with breast cancer when compared to the breath profiles of participants without breast cancer. This project will also assess performance characteristics of the technology (e.g. sensitivity, specificity, false negative rate, and false positive rate) including subgroup analyses. This project aims to understand intra-subject variability by exploring differences in breath signatures before and after definitive management of breast cancer, including surgical resection.
Conditions: Breast Cancer
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Female (sex as assigned at birth);
- Aged 40 - 74 years;
- Mammography confirmed breast tissue density (BI-RADS density score of A, B, C or D);
- Scheduled for standard of care biopsy or MRI;
- Fluent in language of consent (English, Spanish, or French);
- Ability to give informed consent;
- Able to provide a breath sample.
Exclusion Criteria
- Prior history of breast cancer;
- Previous surgical biopsy or surgical excision of breast cancer in the past six months;
- History of cancer (except basal cell or squamous cell carcinoma of the skin) in the past year;
- Acute respiratory infection and/or symptoms in the past seven days;
- MRI BI-RADS 3 undergoing active surveillance (MRI requiring six-month follow-up).
- Pregnant or become pregnant during the study.
Recruiting US locations
GW Comprehensive Breast Center
Washington D.C., DC 20037
Site contact: Geoffrey Rutledge, MD · grutledge@mfa.gwu.edu
Mayo Clinic Breast Clinic
Jacksonville, FL 32224
Site contact: Clinical Trials Referral Office · 855-776-0015
Duke University Medical Cente
Durham, NC 27710
Site contact: Jennifer Plichta, MD · 919-684-6849 · jennifer.plichta@duke.edu
Study contacts (from the official record)
- Sandra Veenstra · (506) 855-2400 · sandra.veenstra@breathebiomedical.com
Similar studies in District of Columbia
All healthy volunteers studies in District of Columbia →- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Washington D.C., DC + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health
International AIDS Vaccine Initiative
- Location
- Washington D.C., DC + 1 other US site
- Eligibility basics
- Ages 18–50
- RecruitingHealthy volunteersPhase 1
A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
International AIDS Vaccine Initiative
- Location
- Washington D.C., DC + 2 other US sites
- Eligibility basics
- Ages 18–50
- RecruitingHealthy volunteersEarly Phase 1
Assistance Delivery and Muscle Coordination
The Catholic University of America
- Location
- Washington D.C., DC
- Eligibility basics
- Ages 20–80